Exane Derivatives’s Carrier Global CARR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$247K Sell
6,935
-16,991
-71% -$667K 0.14% 143
2022
Q1
$1.1M Buy
23,926
+11,408
+91% +$537K 0.31% 79
2021
Q4
$679K Buy
12,518
+7,234
+137% +$390K 0.16% 140
2021
Q3
$273K Buy
5,284
+5,263
+25,062% +$283K 0.07% 312
2021
Q2
$1.03K Hold
21
﹤0.01% 874
2021
Q1
$887 Hold
21
﹤0.01% 747
2020
Q4
$792 Sell
21
-391
-95% -$14.2K ﹤0.01% 699
2020
Q3
$12.6K Hold
412
﹤0.01% 458
2020
Q2
$9.15K Buy
+412
New +$7.66K ﹤0.01% 419

Other funds holding CARR

Exane Derivatives's CARR Position: Q2 2022 in Review

Exane Derivatives reduced its Carrier Global (CARR) stake by 71% in Q2 2022, selling an estimated $667K and leaving 6,935 shares worth $247K. The position accounts for 0.14% of the portfolio, ranked #143.

Exane Derivatives first reported a position in CARR in Q2 2020 and has held it in 9 quarters since. The position peaked at $1.1M in Q1 2022. 1,171 funds tracked by Wall St. Rank hold CARR as of Q2 2022.

  • Exane Derivatives held 6,935 shares of Carrier Global worth $247K as of Q2 2022.
  • Exane Derivatives sold 16,991 Carrier Global shares in Q2 2022, an estimated $667K.
  • Carrier Global made up 0.14% of Exane Derivatives's portfolio in Q2 2022, its #143 holding.
  • Exane Derivatives first reported a position in Carrier Global in Q2 2020 and has held it in 9 quarters since.
  • Exane Derivatives's Carrier Global position peaked at $1.1M in Q1 2022.
  • 1,171 funds tracked by Wall St. Rank held Carrier Global as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.